By Kevin Penton ( February 5, 2019, 10:43 PM EST) -- Allergan wants the U.S. International Trade Commission to probe whether a California-based medical aesthetics company and a South Korean-based pharmaceutical company are violating the Tariff Act with a version of Botox allegedly developed through trade secret violations, the agency announced Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.